Vortioxetine improves symptomatic and functional outcomes in major depressive disorder: a novel dual outcome measure in depressive disorders
Summary. With symptomatic remission and functional recovery as the overarching therapeutic objectives of antidepressant therapy, composite endpoint measures that conjointly consider both aspects of treatment are needed. This analysis evaluated the combined effect of vortioxetine on depressive symptom...
Saved in:
| Main Authors: | М. С. Christensen, Н. Loft, R. S. McIntyre |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Federal State Budget Scientific Institution National Medical Research Center for Psychiatry and Neurology n.a. V.M. Bekhterev Ministry of Health of the Russian Federation
2019-07-01
|
| Series: | Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева |
| Online Access: | https://www.bekhterevreview.com/jour/article/view/250 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A retrospective analysis of vortioxetine utilization in children and adolescents with major depressive disorder in clinical practice
by: Xianmei Luo, et al.
Published: (2025-05-01) -
Efficiency and safety of Vortioxetine in the treatment of depressive disorders in cardiac patients
by: N. V. Filippova, et al.
Published: (2023-06-01) -
Effect of vortioxetine versus venlafaxine on cognitive functions in adults with major depressive disorder: A randomized-controlled trial
by: Chayan K. Manna, et al.
Published: (2023-08-01) -
The efficacy and safety of 10 mg vortioxetine in the treatment of major depressive disorder: a meta-analysis of randomized controlled trials
by: Li G, et al.
Published: (2016-02-01) -
Longitudinal association between somatic symptoms and suicidal ideation in adults with major depressive disorder
by: Subinuer Yiming, et al.
Published: (2025-08-01)